• 9th ANNUAL INDUSTRY AUDIT Professor Bill Trombetta of St Joseph’s University Business School presents his unique roster of the leading company lights in asset and revenue efficiency, drawing from a growing list of companies in big pharma, biotech and generics. Check in to see who will take the top prize as best managed company for 2010. By William Looney, Editor-in-Chief J&J Pfizer Novartis AstraZeneca Abbott Sanofi-Aventis GSK Merck Lilly BMS Amgen Teva Novo Nordisk Gilead Mylan Genzyme Allergan Biogen-IDEC Forest Labs Watson Celgene Cephalon King Endo

• GILEAD SCIENCES: GROWING INTO FOCUS
Pharm Exec sits down to talk with Gilead Executive Vice President for Commercial Operations Kevin Young on the company’s effort to expand its development portfolio while meeting patient expectations for leadership in next generation HIV therapies.

• PFIZER: CHANGING THE DIALOGUE ON IP
The biggest of the big pharma details the challenges – and opportunities – in repositioning the IP function as a driver of commercial and reputational value.

• REINVIGORATING R&D
In preparation for “science’s greatest night,” the 2010 Prix Galien awards on September 28, former HHS Assistant Secretary for Health Dr. Eve Slater and Tufts Center for the Study of Drug Development Executive Director Ken Kaitin document the internal management changes needed to strengthen innovation in new drug discovery.

• SPECIAL SECTION ON PHYSICIAN MEETINGS
Pharm Exec’s annual supplement on Physician Meetings, with latest updates on the legislative and regulatory barriers to interactions between professionals and big pharma – and how companies are coping to maintain the essential human-to-human contacts that drive sales.

Bonus Distribution:
Prix Galien International Awards
PharmaForce
Fleming Gulf Conference
CBI: 3rd Annual Forum on Evolving the Pharma Sales Model
CBI: 9th Annual Portfolio Evolution and Strategic Investment Decision-Making
CBI: 3rd Annual Medical Device and Bio/Pharmaceutical Commercialization
CBI: 4th Annual Bio/Pharmaceutical Collaboration and Transaction Accounting